Skip to main content
Clinical Trials/JPRN-UMIN000053278
JPRN-UMIN000053278
Not yet recruiting
未知

Retrospective observational study comparing comparing post-COVID conditions incidence in COVID-19 patients between ensitrelvir administration and administration/non-administration of anti-SARS-CoV-2 drugs using large-scale health insurance association data in Japan (3-month follow-up) - Retrospective observational study comparing comparing post-COVID conditions incidence in COVID-19 patients between ensitrelvir administration and administration/non-administration of anti-SARS-CoV-2 drugs using large-scale health insurance association data in Japan (3-month follow-up)

Shionogi & Co., Ltd.0 sites300,000 target enrollmentJanuary 9, 2024
ConditionsCOVID-19

Overview

Phase
未知
Intervention
Not specified
Conditions
COVID-19
Sponsor
Shionogi & Co., Ltd.
Enrollment
300000
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 9, 2024
End Date
July 31, 2025
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Shionogi & Co., Ltd.

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Patients under 18 years of age at the time of IM 2\. Patients with dispending days of multiple anti\-SARS\-CoV\-2 drugs in IM 3\. Patients with a COVID\-19 diagnosis within 3 months prior to IM 4\. Patients who have been diagnosed with the same event as the post\-COVID condition within 6 months before IM 5\. Patients at risk of severe COVID\-19

Outcomes

Primary Outcomes

Not specified

Similar Trials